Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute Febrile Encephalopathy (Phase 1)
Antigens, CD19 (Phase 2)
Arthritis, Rheumatoid (Phase 1)
Automobiles (Phase 1)
Blood Transfusion (Phase 2)
Bone Marrow Transplantation (Phase 2)
Burkitt Lymphoma (Phase 3)
Drugs, Investigational (Phase 2)
Electroconvulsive Therapy (Phase 1)
Endoscopy (Phase 1)
Hematologic Neoplasms (Phase 1)
Hodgkin Disease (Phase 2)
Leukemia (Phase 1/Phase 2)
Leukemia, B-Cell (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2/Phase 3)
Leukemia, Prolymphocytic (Phase 1)
Leukemia, Prolymphocytic, B-Cell (Phase 1/Phase 2)
Lupus Erythematosus, Systemic (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 1)
Pediatrics (Phase 2)
POEMS Syndrome (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2/Phase 3)
Recurrence (Phase 1/Phase 2)
Risk Factors (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue